|
|
|
|
|
|
| Global CRO helps drive positive change to enhance clinical development process with extensive presence at industry meeting |
Raleigh, N.C., June 12, 2014 - (ACN Newswire) - INC Research, a leading, global Phase I to IV clinical research organization (CRO), will be showcasing its latest advancements in clinical trial innovation at the DIA 2014 Annual Meeting being held June 15-19 at the San Diego Convention Center. INC experts will present on a broad range of topics across 13 educational sessions representing the latest trends and thinking in clinical development. The Company will be a featured presenter at DIA's Innovation Theater, providing insights to biopharmaceutical organizations implementing innovations that will drive efficiencies and continue to accelerate the way in which new medicines are developed. INC Research executives will be on-hand throughout the duration of the meeting at Booth #1313 to discuss how the Company is driving deeper connections through its therapeutically aligned teams, more transparent and real-time study data and outreach with diverse research communities to engage the patients that best fit customers' studies.
"INC Research continues to explore new and innovative solutions to accelerate the development of new therapies to market safely, efficiently and at the highest level of quality for our customers," said INC Research CEO Jamie Macdonald. "The DIA Annual Meeting provides an ideal forum to connect with key stakeholders across the clinical development process and share the latest thinking on how we as an industry can work more effectively together for the benefit of patients. INC is looking forward to actively contributing to these discussions. At this year's meeting in particular we have a special event planned to thank and connect with our investigative site partners who make a real difference to study success. Enhancing our partnership with this important group will further strengthen our delivery to customers and differentiate INC as we work to become the CRO of choice for pharmaceutical and biotech companies worldwide."
INC Research will be participating in the following events at the DIA 2014 Annual Meeting:
CISCRP Medical Heroes 5K Walk/Run
INC Research is an Elite Sponsor of the CISCRP's inaugural 5K Run & Walk that will coincide with the DIA 2014 Annual Meeting. INC Research CEO Jamie MacDonald and a team made up of INC employees will take part in the Run/Walk on Monday, June 16 at 6:45 a.m. The event will celebrate the volunteers who participate in clinical research, with proceeds supporting education and outreach programs to patients and families. To register, visit http://bit.ly/PwSknr.
Join INC at the Innovation Theater
INC Research's participation in this year's DIA Innovation Theater will feature "Organizing for Change.Lessons Learned in Preparing a Global Organization for Innovation." This event will take place June 16 from 1 to 2 p.m. in the Exhibit Hall and will address the growing pressure for the industry to reduce development costs and ensure better outcomes from clinical trials. If the necessary strategic innovations are identified and drive technological and organizational changes, these pressures can be translated into opportunities. John A. Whitaker, Ph.D., Senior Vice President, Clinical Innovation and Kari Delahunty, Senior Director, Corporate Strategy will highlight key elements in delivering innovation through successful organizational change.
Investigative Site Reception
As part of its ongoing commitment to strengthen site relationships globally, INC Research is hosting a private reception and networking event for site investigators on Tuesday, June 17, from 6 to 9 p.m. As a Global Impact Partner with the Society for Clinical Research Sites (SCRS), INC is broadening its relationships with sites even further in an effort to gain insights into how the industry can improve the quality and depth of support that sites receive. INC Research CEO Jamie Macdonald and COO Alistair Macdonald along with SCRS President Christine Pierre will be on-site to meet with site investigators and discuss ways to work better together. For more information on this event, interested sites should visit Booth #1313.
Speaking Program
Additionally, the following INC Research thought leaders will continue the clinical innovation conversation in the indicated speaker sessions:
-- Elaine Taylor, Director, Regulatory Strategy, Consulting, and Submissions -"Successful Drug Development: Best Practices for Clinical Trial Design, Agency Interactions and Regulatory Document Writing" (Pre-Show Tutorial, June 15, 8:30 a.m. - 12 p.m., Room #3)
-- Andy Townshend, Vice President, Alliance Development - "Risk Sharing or Risk Transfer? Striking the Perfect Balance in Strategic Partnerships" (Forum, June 16, 11:00 a.m. - 12:30 p.m., Room #3)
-- Rosie McKellar, Senior Director, Clinical Operations - "Monitor Training: Building Essential Skills for Implementing Risk-Based Monitoring - Data Interpretation, Quality by Design" (Workshop, June 17, 8:00 - 9:30 a.m., Room #16A)
-- Tony Womack, Executive Director, Medical Writing - "Understanding Periodic Benefit-Risk Evaluation Reports," as part of "Update on Postmarking Safety Reporting" (Session, June 17, 10:30 a.m. - 12:00 p.m., Room #30AB)
-- Kathy Bohannon, Executive Director, Strategic Alliances - "Pediatric Safety Monitoring: Role of IRBs and DSMBs," as part of "How Do We Keep Kids Safe? Pediatric Safety Monitoring From Beginning to End" (Symposium, June 17, 1:30 - 3:00 p.m., Room #4)
-- Keith Ruark, Vice President, AVOS Consulting - "Life Cycle Management of Biopharmaceuticals: An Approach and Lessons Learned for an Imperative Business Practice" (Session, June 18, 8:00 - 9:00 a.m., Room #1A)
-- Luke Hickey, Executive Director, Biostatistics - "So You Want a Career in Biostatistics?" as part of "Your Future Success as a Master's Level Statistician: Learn from the Past of These Industry Masters" (Forum, June 18, 8:00 - 9:30 a.m., Room #5B)
-- Carmen Weese, Senior Vice President, Data Operations - "EDC Rescue Studies: Combining Multiple Datasets to Meet Reporting Requirements," as part of "Maximizing the Potential of Your EDC System" (Symposium, June 18 from 10:30 a.m. - 12:00 p.m., Room #30CD)
-- Andy Townshend, Vice President, Alliance Development - "The CRO-Sponsor Relationship Then and Now: A Look at Past Outsourcing Models and Their Impact on Future Relationships" as part of "The Present and Future of Pharmaceutical Development Outsourcing: Where Are We Today and Where Are We Going?" (Forum, June 18, 10:30 a.m. - 12:00 p.m., Room #4)
-- Andy Townshend, Vice President, Alliance Development - "Functional Service Provider Relationships: Critical Factors to Ensuring Long-Term Success" (Forum, June 18, 1:30 - 3:00 p.m., Room #4)
-- Alistair Macdonald, Chief Operating Officer - "Effective Strategic Partnering Between Small Pharmaceutical Companies and CROs: Discussion and Case Study" (Forum, June 18, 3:30 - 5:00 p.m., Room #4)
-- Drew Kilpatrick, Vice President, Safety and Pharmacovigilance - "Ensuring Standardized Case Quality in Safety and Pharmacovigilance Services through Web-Based Systems," as part of "Changing the Mindset Towards Case Quality, Audits and Inspections: A Practical Approach" (Symposium, June 19, 10:45 a.m. - 12:15 p.m., Room #5A)
-- Keith Dorricott, Senior Director, Quality Operations - "Learnings from Use of Quality Metrics: CRO View" as part of "Bringing Quality to Quality Metrics" (Session, June 19, 10:45 a.m. - 12:15 p.m., Room #8)
For more information or to schedule a meeting at DIA 2014, visit www.incresearch.com or connect with us on social media - LinkedIn, Twitter, Facebook.
LinkedIn: https://www.linkedin.com/company/11776
Twitter: https://twitter.com/inc_research
Facebook: https://www.facebook.com/pages/INC-Research/72665838627?ref=hl
About INC Research
INC Research is a leading, global full-service clinical research organization (CRO) providing the full range of Phase I to IV clinical development services for the world's pharmaceutical, biotech and medical device industries. As a therapeutically focused CRO, with a Trusted Process(R) delivery methodology, developing the medicines people need is something we take personally. Leveraging the breadth of our service offerings and the depth of our therapeutic expertise across multiple patient populations, INC Research connects customers, investigative sites and patients to accelerate the delivery of new medicines to market to improve world health. We were ranked "Top CRO to Work With" by sites worldwide in the 2013 CenterWatch Global Investigative Site Relationship Survey. INC Research is headquartered in Raleigh, NC, with operations across six continents and experience spanning more than 100 countries. For more information, please visit www.incresearch.com and connect with us on LinkedIn and Twitter @inc_research.
Contact:
Lori Dorer, Media +1-513-345-1685
###
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: INC RESEARCH, LLC via Globenewswire
Topic: General Announcement
Source: INC Research, LLC
https://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
|
